Cargando…

Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis

BACKGROUND AND AIM: Several studies have been conducted to examine the associations between osteopontin (OPN) promoter gene SPP1 polymorphisms with human cancers in Chinese population, but the results remain inconsistent. The aim of this meta-analysis is to clarify the associations between SPP1 poly...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yulan, Lei, Hongbo, Zhang, Jixiang, Wang, Jun, Li, Kui, Dong, Weiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534197/
https://www.ncbi.nlm.nih.gov/pubmed/26267616
http://dx.doi.org/10.1371/journal.pone.0135318
_version_ 1782385429758083072
author Liu, Yulan
Lei, Hongbo
Zhang, Jixiang
Wang, Jun
Li, Kui
Dong, Weiguo
author_facet Liu, Yulan
Lei, Hongbo
Zhang, Jixiang
Wang, Jun
Li, Kui
Dong, Weiguo
author_sort Liu, Yulan
collection PubMed
description BACKGROUND AND AIM: Several studies have been conducted to examine the associations between osteopontin (OPN) promoter gene SPP1 polymorphisms with human cancers in Chinese population, but the results remain inconsistent. The aim of this meta-analysis is to clarify the associations between SPP1 polymorphisms and cancer susceptibility. METHODS: All eligible case-control studies published up to March 2015 were identified by searching PubMed, Web of Science, Embase, and Cochrane Library without language restrictions. Pooled odds ratio (OR) and 95% confidence interval (95% CI) were calculated using fixed- or random-effect model. RESULTS: A total of 11 case-control studies were included; of those, there were eleven studies (3130 cases and 3828 controls) for -443T>C polymorphism, ten studies (3019 cases and 3615 controls) for -156G>GG polymorphism, eight studies (2258 cases and 2846 controls) for -66T>G polymorphism. Overall, no evidence indicated that the -443 T>C polymorphism was associated with cancer risk (OR = 0.93, 95%CI 0.62–1.38 for dominant model, OR = 1.06, 95%CI 0.73–1.55 for recessive model, OR = 0.88, 95%CI 0.62–1.26 for CT vs TT model, OR = 1.03, 95%CI 0.61–1.73 for CC vs TT model). While, a significantly increase risk was found for -156 G>GG polymorphism (OR = 1.22, 95%CI 1.10–1.35 for dominant model, OR = 1.25, 95%CI 1.10–1.41 for recessive model, OR = 1.18, 95%CI 1.06–1.32 for GGG vs GG model, OR = 1.35, 95%CI 1.09–1.68 for GGGG vs GG model). For -66T>G polymorphism, we found a decrease risk of cancer (OR = 0.84, 95% CI 0.71–0.98 for dominant model), but this result changed (OR = 0.93, 95% CI 0.77–1.12 for dominant model) when we excluded a study. CONCLUSION: This meta-analysis suggests that in Chinese population the -156G>GG polymorphism of SPP1 might be a risk factor for human cancers, while -443T>C mutation is not associated with cancer risk. For -66T>G polymorphism, it may be a protective factor for human cancers.
format Online
Article
Text
id pubmed-4534197
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45341972015-08-24 Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis Liu, Yulan Lei, Hongbo Zhang, Jixiang Wang, Jun Li, Kui Dong, Weiguo PLoS One Research Article BACKGROUND AND AIM: Several studies have been conducted to examine the associations between osteopontin (OPN) promoter gene SPP1 polymorphisms with human cancers in Chinese population, but the results remain inconsistent. The aim of this meta-analysis is to clarify the associations between SPP1 polymorphisms and cancer susceptibility. METHODS: All eligible case-control studies published up to March 2015 were identified by searching PubMed, Web of Science, Embase, and Cochrane Library without language restrictions. Pooled odds ratio (OR) and 95% confidence interval (95% CI) were calculated using fixed- or random-effect model. RESULTS: A total of 11 case-control studies were included; of those, there were eleven studies (3130 cases and 3828 controls) for -443T>C polymorphism, ten studies (3019 cases and 3615 controls) for -156G>GG polymorphism, eight studies (2258 cases and 2846 controls) for -66T>G polymorphism. Overall, no evidence indicated that the -443 T>C polymorphism was associated with cancer risk (OR = 0.93, 95%CI 0.62–1.38 for dominant model, OR = 1.06, 95%CI 0.73–1.55 for recessive model, OR = 0.88, 95%CI 0.62–1.26 for CT vs TT model, OR = 1.03, 95%CI 0.61–1.73 for CC vs TT model). While, a significantly increase risk was found for -156 G>GG polymorphism (OR = 1.22, 95%CI 1.10–1.35 for dominant model, OR = 1.25, 95%CI 1.10–1.41 for recessive model, OR = 1.18, 95%CI 1.06–1.32 for GGG vs GG model, OR = 1.35, 95%CI 1.09–1.68 for GGGG vs GG model). For -66T>G polymorphism, we found a decrease risk of cancer (OR = 0.84, 95% CI 0.71–0.98 for dominant model), but this result changed (OR = 0.93, 95% CI 0.77–1.12 for dominant model) when we excluded a study. CONCLUSION: This meta-analysis suggests that in Chinese population the -156G>GG polymorphism of SPP1 might be a risk factor for human cancers, while -443T>C mutation is not associated with cancer risk. For -66T>G polymorphism, it may be a protective factor for human cancers. Public Library of Science 2015-08-12 /pmc/articles/PMC4534197/ /pubmed/26267616 http://dx.doi.org/10.1371/journal.pone.0135318 Text en © 2015 Liu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Liu, Yulan
Lei, Hongbo
Zhang, Jixiang
Wang, Jun
Li, Kui
Dong, Weiguo
Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis
title Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis
title_full Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis
title_fullStr Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis
title_full_unstemmed Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis
title_short Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis
title_sort associations between the genetic polymorphisms of osteopontin promoter and susceptibility to cancer in chinese population: a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534197/
https://www.ncbi.nlm.nih.gov/pubmed/26267616
http://dx.doi.org/10.1371/journal.pone.0135318
work_keys_str_mv AT liuyulan associationsbetweenthegeneticpolymorphismsofosteopontinpromoterandsusceptibilitytocancerinchinesepopulationametaanalysis
AT leihongbo associationsbetweenthegeneticpolymorphismsofosteopontinpromoterandsusceptibilitytocancerinchinesepopulationametaanalysis
AT zhangjixiang associationsbetweenthegeneticpolymorphismsofosteopontinpromoterandsusceptibilitytocancerinchinesepopulationametaanalysis
AT wangjun associationsbetweenthegeneticpolymorphismsofosteopontinpromoterandsusceptibilitytocancerinchinesepopulationametaanalysis
AT likui associationsbetweenthegeneticpolymorphismsofosteopontinpromoterandsusceptibilitytocancerinchinesepopulationametaanalysis
AT dongweiguo associationsbetweenthegeneticpolymorphismsofosteopontinpromoterandsusceptibilitytocancerinchinesepopulationametaanalysis